An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Part of paid clinical trials in Los Angeles, California.

Sponsor
Regeneron Pharmaceuticals
Study ID
NCT05106387
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Kidney Disease (CKD)

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Noninterventional — DRUG
    No investigational treatment will be given in this noninterventional extension study

Study Details

The main purpose of this study is to continue to see how vonsetamig works in the body and to monitor the outcomes after kidney transplant for participants previously treated in the R5459-RT-1944 study (NCT05092347). No study drug will be given during this study.

Key Dates

Start date
Oct 19, 2023
Status verified
Apr 2026
Primary completion
Jun 15, 2026
Completion
Feb 23, 2028

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Vonsetamig in study R5459-RT-1944
    Received a kidney transplant and were administered vonsetamig in study R5459-RT-1944 \[NCT05092347\].

Primary Outcome Measure

Incidence of Adverse Events [ Time Frame: Up to 12 months post-kidney transplant ]

Central Contacts

Locations (9)

FacilityCityStateZIPSite coordinators
Cedars-Sinai Medical CenterLos AngelesCalifornia90048-
University of California IrvineOrangeCalifornia92868-
Connie Frank Transplant Center at UCSFSan FranciscoCalifornia94143-
Yale University of MedicineNew HavenConnecticut06520-
Comprehensive Transplant CenterChicagoIllinois60611-
John Hopkins HospitalBaltimoreMaryland21224-
University of MinnesotaMinneapolisMinnesota55455-
New York University Langone HealthNew YorkNew York10016-
Penn Transplant InstitutePhiladelphiaPennsylvania19104-

Find similar trials in Los Angeles, CA

By research site
Cedars-Sinai Medical Center· Los Angeles, CAUniversity of California Irvine· Orange, CAConnie Frank Transplant Center at UCSF· San Francisco, CAYale University of Medicine· New Haven, CTComprehensive Transplant Center· Chicago, ILJohn Hopkins Hospital· Baltimore, MD

Related Studies